Clinical presentation and treatment of gastric metastasis from other malignancies of solid organs

  • Authors:
    • Tsutomu Namikawa
    • Eri Munekage
    • Maho Ogawa
    • Toyokazu  Oki
    • Masaya  Munekage
    • Hiromichi Maeda
    • Hiroyuki Kitagawa
    • Takeki  Sugimoto
    • Michiya Kobayashi
    • Kazuhiro Hanazaki
  • View Affiliations

  • Published online on: July 6, 2017     https://doi.org/10.3892/br.2017.943
  • Pages: 159-162
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to analyze the clinicopathologic features and treatment outcomes of gastric metastasis from other malignancies of solid organs. A review was conducted of patients with metastatic tumors in the stomach from other malignancies of solid organs detected endoscopically at the Department of Surgery, Kochi Medical School, from January 1991 to December 2015. Seven patients (four men and three women), with a median age of 64 years (range, 42‑71 years), had metastatic gastric tumors. Median tumor size was 7.3 cm (range, 2.5‑12.0 cm). The primary malignancy leading to metastatic tumors in the stomach was esophageal cancer in three patients, breast cancer in two patients, renal cell carcinoma in one patient, and ovarian cancer in one patient. Gastric metastasis presented as solitary lesions in six patients and as multiple lesions in one patient. Four patients had solitary gastric metastasis, whereas three had multiple metastases in other organs. The median tumor size was significantly smaller in patients with solitary rather than multiple metastases (4.6 vs. 12.0 cm, respectively; P=0.038). Three patients received systemic therapy and four underwent surgical resection of the metastatic tumor, and of these, only one was alive 58 months after surgery. Clinicians should be aware of the possible existence of metastatic gastric cancer, especially in breast carcinoma and esophageal cancer. Surgical resection may considerably improve patients' quality of life, and could be of benefit when there is a risk of bleeding and/or a solitary metastasis.
View Figures
View References

Related Articles

Journal Cover

August-2017
Volume 7 Issue 2

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Namikawa T, Munekage E, Ogawa M, Oki T, Munekage M, Maeda H, Kitagawa H, Sugimoto T, Kobayashi M, Hanazaki K, Hanazaki K, et al: Clinical presentation and treatment of gastric metastasis from other malignancies of solid organs. Biomed Rep 7: 159-162, 2017
APA
Namikawa, T., Munekage, E., Ogawa, M., Oki, T., Munekage, M., Maeda, H. ... Hanazaki, K. (2017). Clinical presentation and treatment of gastric metastasis from other malignancies of solid organs. Biomedical Reports, 7, 159-162. https://doi.org/10.3892/br.2017.943
MLA
Namikawa, T., Munekage, E., Ogawa, M., Oki, T., Munekage, M., Maeda, H., Kitagawa, H., Sugimoto, T., Kobayashi, M., Hanazaki, K."Clinical presentation and treatment of gastric metastasis from other malignancies of solid organs". Biomedical Reports 7.2 (2017): 159-162.
Chicago
Namikawa, T., Munekage, E., Ogawa, M., Oki, T., Munekage, M., Maeda, H., Kitagawa, H., Sugimoto, T., Kobayashi, M., Hanazaki, K."Clinical presentation and treatment of gastric metastasis from other malignancies of solid organs". Biomedical Reports 7, no. 2 (2017): 159-162. https://doi.org/10.3892/br.2017.943